Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nervenarzt ; 79(1): 86-9, 2008 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-17924089

RESUMO

Malignant neuroleptic syndrome (MNS) is a rare side effect of antipsychotic medications but means a serious and life-threatening complication. The risk of MNS seems to be lower for second generation antipsychotics (SGA). We report the 9-month history of a 42-year-old female patient whose antipsychotic medication was switched to 800 mg per day of amisulpride. Two weeks after discharge she suffered muscular pain, stiffness, weakness of the legs, rigor, and fever. After attending our outpatient department and being diagnosed, she was transferred to the neurological intensive unit, where the creatine kinase (CK) level was measured at 160,000 U/l. Furthermore extensive rhabdomyolysis accompanied by a compartment syndrome was seen. Surgical intervention was necessary for the latter. The patient was then retransferred to the psychiatric department after treatment with lorazepam and withdrawal of antipsychotic medications. In addition a therapy with valproate sodium was conducted. Long-term high levels of CK and abnormalities in the electromyogram led to the hypothesis of myopathy as a possible risk factor, but a final diagnostic classification was not feasible. This report describes the appearance of a MNS as a consequence of SGA therapy, discusses risk factors and therapy options, and shows the 9-month course.


Assuntos
Antipsicóticos/efeitos adversos , Síndrome Maligna Neuroléptica/diagnóstico , Esquizofrenia Paranoide/tratamento farmacológico , Sulpirida/análogos & derivados , Transtornos Psicóticos Afetivos/diagnóstico , Transtornos Psicóticos Afetivos/tratamento farmacológico , Amissulprida , Anticonvulsivantes/uso terapêutico , Antipsicóticos/uso terapêutico , Creatina Quinase/sangue , Diagnóstico Diferencial , Eletromiografia/efeitos dos fármacos , Feminino , Seguimentos , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/patologia , Esquizofrenia Paranoide/diagnóstico , Sulpirida/efeitos adversos , Sulpirida/uso terapêutico , Ácido Valproico/uso terapêutico
2.
Radiologe ; 38(4): 307-14, 1998 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-9622825

RESUMO

The diagnostic impact and reproducibility of the different methods used within the concept of functional MR-Mammography (FMRM) was assessed by a multi-reader-analysis. By four experienced readers, 100 histologically confirmed cases were evaluated in six different sessions. Per session, one of the following components was analyzed: clinical history (I), static MRM (II), color-coded projection images (III), time-signal curves of contrast enhancement within a large ROI (IV) and the strongest enhancing pixel (V) obtained from the histologically confirmed lesion and the complete FMRM reading (VI). The functional methods (IV-VI) revealed significantly (p < 0.05) higher specificities than the others (I-III). The highest reproducibility between the readers was observed for (IV) phi chi = 0.80, (V) phi chi = 0.76 and FMRM (VI) phi chi = 0.63. These three methods also presented the best ROC-curves and showed the highest complementarity with respect to the false positive classifications in x-ray mammography. FMRM is a reader independent, reproducible method. The analysis of the contrast enhancement time-intensity curves with high temporal resolution allows an improved differentiation of malignant and benign findings.


Assuntos
Neoplasias da Mama/diagnóstico , Imageamento por Ressonância Magnética/estatística & dados numéricos , Mamografia/estatística & dados numéricos , Adulto , Idoso , Mama/patologia , Neoplasias da Mama/patologia , Carcinoma Ductal de Mama/diagnóstico , Carcinoma Ductal de Mama/patologia , Carcinoma Lobular/diagnóstico , Carcinoma Lobular/patologia , Meios de Contraste , Feminino , Doença da Mama Fibrocística/diagnóstico , Doença da Mama Fibrocística/patologia , Humanos , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Variações Dependentes do Observador , Estudos Prospectivos , Curva ROC , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA